DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ)
$10.08 0.01 (0.0993%)
Analysed DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) News Sources
NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave
24-02-2026
fool.com
Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company
04-12-2025
yahoo.com
Drugs Made In America Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing December 3, 2025
03-12-2025
yahoo.com
Drugs Made In America Acquisition II Corp. Announces Closing of $500,000,000 Initial Public Offering
26-09-2025
yahoo.com
Drugs Made In America Acquisition II Corp. Announces Pricing of $500,000,000 Initial Public Offering
25-09-2025
yahoo.com
What is the current price of DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ)?
The current price of DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) is $10.08.
DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) absolute price change since previous trading day?
The absolute price change of DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) since the previous trading day is $0.01.
DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) percentage price change since previous trading day?
The percentage price change of DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) since the previous trading day is 0.0993%.
What is the most recent average sentiment score for DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ)?
The most recent average sentiment score for DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) is 66 out of 100.
What is the most recent average sentiment for DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ)?
The most recent sentiment for DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ) is .
SEC-8K** Filing Available For DRUGS MADE IN AMERICA ACQUIS (DMIIU:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.